Literature DB >> 31756351

Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.

Erika L Thompson1, Annalynn M Galvin2, Ellen M Daley3, Ovidiu Tatar4, Gregory D Zimet5, Zeev Rosberger6.   

Abstract

Cervical cancer screening guidelines in the United States were revised in 2018 to include the option of primary human papillomavirus (HPV) testing. The transition to this screening method may face difficulties as Pap testing has been the primary screening modality in the United States. The objective of this study is to assess information, motivation, and behavioral skills associated with willingness to receive an HPV test instead of a Pap test among women. The sample included U.S. 812 women, ages 30 to 65 years. Participants completed an online survey in 2018. The Information, Motivation, and Behavioral Skills (IMB) model was used to measure predictors of willingness for HPV testing. The outcome variables were willingness to receive the HPV test instead of the Pap test, with and without time interval details. Logistic regression modeling was used with SAS 9.4. Over half of the sample (55%) were willing to receive the HPV test. For the information domain, HPV knowledge was significantly associated with willingness for HPV testing (OR = 1.08, 95%CI 1.04-1.13). Significant motivating factors included: positive attitudes, social norms, perceived benefits, worry about cervical cancer, and worry about abnormal HPV tests. For behavioral skills, women were significantly more willing to get the HPV test if a provider recommended it (OR = 2.43, 95%CI 1.53-3.87) and currently up-to-date on cervical cancer screening guidelines (OR = 1.52, 95%CI 1.52-2.26). Addressing barriers and facilitators to willingness to transition to primary HPV testing over Pap testing is needed as the United States has updated guidelines for cervical cancer screening.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Guidelines; Human papillomavirus (HPV); Screening; Women

Mesh:

Year:  2019        PMID: 31756351     DOI: 10.1016/j.ypmed.2019.105928

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

1.  Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?

Authors:  Hitomi Kariya; Diana S M Buist; Melissa L Anderson; John Lin; Hongyuan Gao; Linda K Ko; Rachel L Winer
Journal:  Prev Med       Date:  2021-11-17       Impact factor: 4.018

2.  The role of primary care Nurse Practitioners in reducing barriers to cervical cancer screening: A literature review.

Authors:  Elizabeth M King; David S Busolo
Journal:  Can Oncol Nurs J       Date:  2022-04-01

3. 

Authors:  Elizabeth M King; David S Busolo
Journal:  Can Oncol Nurs J       Date:  2022-04-01

4.  Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.

Authors:  Jin Qin; Shahram Shahangian; Mona Saraiya; Hunter Holt; Maribeth Gagnon; George F Sawaya
Journal:  Gynecol Oncol       Date:  2021-09-08       Impact factor: 5.482

5.  The Acceptance of Human Papillomavirus Self-Sampling Test among Muslim Women:A Systematic Review.

Authors:  Siti Maisara Amir; Idayu Badilla Idris; Hanizah Mohd Yusoff
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01

6.  Willingness to utilize cervical cancer screening among Ethiopian women aged 30-65 years.

Authors:  Adugna Alemu Desta; Fikadu Tolesa Alemu; Moges Beya Gudeta; Dejene Edosa Dirirsa; Andualem Gezahegn Kebede
Journal:  Front Glob Womens Health       Date:  2022-08-30

7.  Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study.

Authors:  Sylvia Kaljouw; Erik E L Jansen; Clare A Aitken; Inge M C M de Kok
Journal:  BJOG       Date:  2022-05-06       Impact factor: 7.331

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.